Data gathered: October 17
Alternative Data for Zoetis
About Zoetis
Zoetis is the leading animal health company, dedicated to supporting its customers and their businesses. Building on more than 65 years of experience in animal health, Zoetis discovers, develops, manufactures and commercializes medicines, vaccines and diagnostic products, which are complemented by biodevices, genetic tests and precision livestock farming.
| Price | $144.06 |
| Target Price | Sign up |
| Volume | 3,360,000 |
| Market Cap | $63.5B |
| Year Range | $141.11 - $173.12 |
| Dividend Yield | 1.31% |
| PE Ratio | 24.66 |
| Analyst Rating | 89% buy |
| Earnings Date | November 4 '25 |
| Industry | Pet Care |
In the news
 |
How Lenivia Approvals at Zoetis (ZTS) Have Changed Its Innovation Pipeline and Recurring Revenue OutlookOctober 15 - Yahoo |
|
Zoetis Announces Health Canada Approval of Lenivia® (izenivetmab injection) for Alleviation of Osteoarthritis (OA) Pain in DogsOctober 14 - Yahoo |
|
Why Zoetis (ZTS) is Poised to Beat Earnings Estimates AgainOctober 14 - Yahoo |
|
Zoetis Gains CVMP Backing for Lenivia, Eyes EU Approval in Dog OA PainOctober 13 - Yahoo |
 |
Zoetis receives positive opinion from CVMP for LeniviaOctober 10 - Thefly.com |
|
Zoetis Receives Positive Opinion from CVMP for Lenivia® (izenivetmab) to Reduce Pain Associated with Osteoarthritis (OA) in DogsOctober 10 - Yahoo |
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q2 '25 | 2.46B | 682M | 1.78B | 718M | 1.08B | 1.610 |
| Q1 '25 | 2.22B | 654M | 1.57B | 631M | 988M | 1.480 |
| Q4 '24 | 2.32B | 741M | 1.58B | 581M | 911M | 1.400 |
| Q3 '24 | 2.39B | 736M | 1.65B | 682M | 1.06B | 1.580 |
| Q2 '24 | 2.36B | 703M | 1.66B | 624M | 970M | 1.560 |
Insider Transactions View All
| Lagano Roxanne filed to sell 15,129 shares at $170. June 4 '25 |
| Reed Willie M filed to sell 11,245 shares at $166.1. March 11 '25 |
| Lagano Roxanne filed to sell 15,781 shares at $170. March 11 '25 |
| PECK KRISTIN C filed to sell 94,194 shares at $156.7. February 20 '25 |
| Lagano Roxanne filed to sell 16,107 shares at $171.2. February 11 '25 |
Similar companies
| Company | Price | AI Score | |
|---|---|---|---|
 |
ChewyCHWY |
$37.44 1.8% | 42 |
 |
PetcoWOOF |
$3.53 1.7% | 43 |
 |
PetMedsPETS |
$2.51 1.2% | 29 |
 |
BARKBARK |
$0.79 2.6% | 24 |
|
ChewyCHWY |
$37.44 1.8% | 42 |
Congress Trading View All
| Politician | Filing Date | Type | Size |
|---|---|---|---|
| Rick Larsen |
Oct 17, 25 | Sell | $1K - $15K |
| Lisa McClain |
Aug 13, 25 | Buy | $1K - $15K |
| Lisa McClain |
Aug 13, 25 | Buy | $1K - $15K |
Read more about Zoetis (ZTS) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, job posts, sentiment, webpage traffic, employee rating, google trends, patents, app downloads, 4chan mentions, facebook engagement, facebook followers, instagram followers, reddit mentions, stocktwits mentions, stocktwits subscribers, twitter followers, twitter mentions, x mentions, youtube subscribers, news mentions, customer reviews, business outlook & linkedin employees.
What is the Market Cap of Zoetis?
The Market Cap of Zoetis is $63.5B.
What is Zoetis' PE Ratio?
As of today, Zoetis' PE (Price to Earnings) ratio is 24.66.
When does Zoetis report earnings?
Zoetis will report its next earnings on November 4 '25.
What is the current stock price of Zoetis?
Currently, the price of one share of Zoetis stock is $144.06.
How can I analyze the ZTS stock price chart for investment decisions?
The ZTS stock price chart above provides a comprehensive visual representation of Zoetis' stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Zoetis shares. Our platform offers an up-to-date ZTS stock price chart, along with technical data analysis and alternative data insights.
Does ZTS offer dividends to its shareholders?
Yes, Zoetis (ZTS) offers dividends to its shareholders, with a dividend yield of 1.31%. This dividend yield represents Zoetis' commitment to providing value to its shareholders through both potential capital appreciation and steady income. Investors considering Zoetis in their portfolio should factor in this dividend policy alongside the company's growth prospects and market position.
What are some of the similar stocks of Zoetis?
Some of the similar stocks of Zoetis are Chewy, Petco, PetMeds, BARK, and Chewy.
.
